Boston, Massachusetts, United States, June 2026 — Medtronic has appointed Eric Lenard, CMA, CFM, as Vice President & Chief Financial Officer (CFO), Innovation, Development & Quality, bringing onboard a seasoned finance executive with extensive leadership experience across global healthcare, medical technology, innovation, and enterprise finance organizations.
In his new role, Lenard will serve as the finance leader for Medtronic’s Global Innovation, Development & Quality organizations, aligning the company’s long-term research and development roadmap with enterprise financial strategy, capital allocation priorities, and value creation objectives. His appointment comes as Medtronic continues to accelerate innovation across healthcare technologies aimed at addressing some of the world’s most complex medical challenges.
Lenard joins Medtronic after an accomplished 22-year career at Johnson & Johnson, where he held a series of increasingly senior leadership positions across finance, treasury, operations, and business strategy. Most recently, he served as Vice President, Global Services Finance, leading enterprise-wide finance operations across multiple sectors and regions while overseeing a global organization of more than 2,000 finance professionals.
Earlier, he served as Vice President of Finance & CFO, Robotics & Digital Solutions, where he provided strategic financial leadership for one of Johnson & Johnson MedTech’s most innovative and rapidly growing businesses. In this role, he partnered closely with executive leadership to advance digital surgery strategies, support innovation investments, oversee financial planning and analysis, and evaluate acquisition and licensing opportunities that helped shape the future of healthcare technology.
His extensive Johnson & Johnson tenure also included leadership positions such as Senior Director, Corporate Treasury, Senior Director of Finance for the DePuy Synthes Global Franchise, Worldwide Senior Director of Finance for DePuy Synthes Spine, and multiple finance leadership assignments across operations, manufacturing, supply chain, and new business development. These roles provided him with deep expertise in capital strategy, mergers and acquisitions, financial risk management, innovation finance, operational governance, and global business leadership.
Prior to Johnson & Johnson, Lenard spent more than six years with Procter & Gamble, where he held several finance leadership positions supporting manufacturing operations, category finance, profit forecasting, strategic planning, and business transformation initiatives. Throughout his career, he has built a reputation for combining financial discipline with strategic vision to support growth, innovation, and long-term value creation.
His appointment reflects Medtronic’s commitment to strengthening the financial leadership supporting its innovation ecosystem and advancing breakthrough technologies that improve patient outcomes worldwide.
About Medtronic
Medtronic is a global healthcare technology leader dedicated to tackling some of the most challenging health issues facing humanity through innovation. The company develops and delivers transformative medical technologies, services, and solutions that improve patient outcomes and enhance healthcare delivery worldwide.
With a strong focus on research, development, and quality, Medtronic continues to pioneer innovations across a broad range of therapeutic areas, helping patients live healthier and more fulfilling lives while supporting healthcare providers with advanced medical technologies.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
